Development of the Port Delivery System With Ranibizumab for Neovascular AMD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Current Opinion in Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Development of the Port Delivery System with ranibizumab for neovascular age-related macular degeneration
Curr Opin Ophthalmol 2022 May 01;33(3)131-136, AP Adamis, E de JuanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.